Optilume Registry for Treatment of Stricture of the Anterior Urethra

NCT05479422 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-02-24

No results posted yet for this study

Summary

The purpose of this registry is verifying the continued safety and effectiveness of the Optilume DCB clinical use in patients undergoing dilation of the urethral stricture.

Conditions

  • Anterior Urethral Stricture, Male

Sponsors & Collaborators

  • Laborie Medical Technologies Inc.

    collaborator INDUSTRY
  • European Association of Urology Research Foundation

    lead OTHER

Principal Investigators

  • Nadir I. Osman · Sheffield Teaching Hospitals NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-13
Primary Completion
2029-08-15
Completion
2029-08-15

Countries

  • Belgium
  • Italy
  • Norway
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05479422 on ClinicalTrials.gov